Intervention Review

You have free access to this content

Pre-admission antibiotics for suspected cases of meningococcal disease

  1. Thambu D Sudarsanam1,*,
  2. Priscilla Rupali2,
  3. Prathap Tharyan3,
  4. Ooriapadickal Cherian Abraham2,
  5. Kurien Thomas4

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 2 AUG 2013

Assessed as up-to-date: 3 MAY 2013

DOI: 10.1002/14651858.CD005437.pub3


How to Cite

Sudarsanam TD, Rupali P, Tharyan P, Abraham OC, Thomas K. Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD005437. DOI: 10.1002/14651858.CD005437.pub3.

Author Information

  1. 1

    Christian Medical College, Medicine Unit 2, Vellore, Tamil Nadu, India

  2. 2

    Christian Medical College, Department of General Medicine Unit -1 & Infectious Diseases, Vellore, Tamil Nadu, India

  3. 3

    Christian Medical College, South Asian Cochrane Network & Centre, Prof. BV Moses & ICMR Advanced Centre for Research & Training in Evidence Informed Health Care, Vellore, Tamil Nadu, India

  4. 4

    Oman Medical Specialty Board, Seeb, Oman

*Thambu D Sudarsanam, Medicine Unit 2, Christian Medical College, Vellore, Tamil Nadu, 632 004, India. thambu@cmcvellore.ac.in.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 2 AUG 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Nathan 2005 {published and unpublished data}
  • Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 2005;366:308-13.

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Barquet 1997 {published data only}
  • Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, et al. Prognostic factors in meningococcal disease: Development of a bedside predictive model and scoring system. JAMA 1997;278(6):491-6.
Barquet 1999 {published data only}
  • Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, et al. Meningococcal disease in a large urban population (Barcelona, 1987 - 1992): predictors of dismal prognosis. Archives of Internal Medicine 1999;159(19):2329-40.
Barson 1985 {published data only}
  • Barson WJ, Miller MA, Brady MT, Powell DA. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children. Pediatric Infectious Disease 1985;4(4):362-8. [: CN-00039069]
Bohr 1983 {published data only}
  • Bohr V, Rasmussen N, Hansen B, Kjersem H, Jessen O, Johnsen N, et al. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. Journal of Infection 1983;7(3):93-202.
BSSI 1995 {published data only}
  • BSSI Research Committee. Bacterial meningitis: causes for concern. Journal of Infection 1995;30(2):89-94. [: 7478351]
Cartwright 1992 {published data only}
  • Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. BMJ 1992;305(6846):143-7.
Congeni 1984 {published data only}
  • Congeni BL. Comparison of ceftriaxone and traditional therapy of bacterial meningitis. Antimicrobial Agents & Chemotherapy 1984;25(1):40-4. [: CN-00033949]
del Rio 1983 {published data only}
  • del Rio MA, Chrane D, Shelton S, McCracken GH Jr, Nelson JD. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet 1983;321(8336):1241-4. [: CN-00031211]
Gedde-Dahl 1990 {published data only}
  • Gedde-Dahl TW, Hoiby EA, Brandtzaeg P, Eskerud JR, Bovre K. Some arguments on early hospital admission and treatment of suspected meningococcal disease cases. NIPH Annals 1990;13(2):45-60.
Girgis 1989 {published data only}
  • Girgis NI, Farid Z, Mikhail IA, Farrag I, Sultan Y, Kilpatrick ME. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal 1989;8(12):848-51. [: CN-00066058]
Gunn 1996 {published data only}
  • Gunn A, Hollyoak V. Meningitis: public health issues. Nursing Times 1996;92(6):27-9.
Harnden 2006 {published data only}
  • Harnden A, Ninis N, Thompson M, Perera R, Levin M, Mant D, et al. Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study. BMJ 2006;332(7553):1295-8. [: BMJ, doi:10.1136/bmj.38789.723611.55]
Jolly 2001 {published data only}
  • Jolly K, Stewart G. Epidemiology and diagnosis of meningitis: results of a five-year prospective, population-based study. Communicable Disease and Public Health 2001;4(2):124-9.
Kavaliotis 1989 {published data only}
  • Kavaliotis J, Manios SG, Kansouzidou A, Danielidis V. Treatment of childhood bacterial meningitis with ceftriaxone once daily: open, prospective, randomized, comparative study of short-course versus standard-length therapy. Chemotherapy 1989;35(4):296-303. [: CN-00061937]
Leclerc 2001 {published data only}
  • Leclerc F, Noizet O, Dorkenoo A, Cremer R, Leteurtre S, Sadik A, et al. Treatment of meningococcal purpura fulminans. Archives de Pediatrie 2001;8(Suppl 4):667-88. [MEDLINE: 2001324586]
Martin 1990 {published data only}
  • Martin E, Hohl P, Guggi T, Kayser FH, Fernex M. Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: clinical results. Infection 1990;18(2):70-7. [: CN-00067277]
Molyneux 2011 {published data only}
  • Molyneux E, Nizami SQ, Saha S, Huu KT, Azam M, Bhutta ZA, et al. 5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study. Lancet 2011;377(9780):1837-45.
Newcombe 1997 {published data only}
  • Newcombe J, Dyer S, Blackman L, Cartwright K, Palmer WH, McFadden J. PCR-single-stranded confirmational polymorphism analysis for non-culture-based subtyping of meningococcal strains in clinical specimens. Journal of Clinical Microbiology 1997;35(7):1809-12.
Noorgard 2002 {published data only}
  • Noorgard B, Soorensen HT, Jensen ES, Faber T, Schoonheyder HC, et al. Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: a Danish population-based cohort study. Journal of Infection 2002;45(3):144-51.
Pecoul 1991 {published data only}
  • Pecoul B, Varaine F, Keita M, Soga G, Djibo A, Soula G, et al. Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet 1991;338(8771):862-6. [: CN-00078644]
Perea-Milla 2009 {published data only}
  • Perea-Milla E, Olalla J, Sanchez-Cantalejo E, Martos F, Matute-Cruz P, Carmona-Lopez G, et al. Pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias. BMC Public Health 2009;9:95. [: Research Support, Non-U.S. Gov't 19344518]
Quagliarello 2003 {published data only}
Riordan 2001 {published data only}
Rodriguez 1986 {published data only}
  • Rodriguez WJ, Puig JR, Khan WN, Feris J, Gold BG, Sturla C. Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations. Pediatric Infectious Disease 1986;5(4):408-15. [: CN-00043513]
Roord 2001 {published data only}
  • Roord JJ, Kaandorp CJ. CBO-guideline 'Bacterial meningitis'. Nederlands Tijdschrift voor Geneeskunde 2001;145(5):211-4.
Roznovsky 2003 {published data only}
  • Roznovsky L, Krizova P, Struncova V, Dostal V, Plisek S, Kasal E, et al. Administration of antibiotics before admission in patients with meningococcal disease. Central European Journal of Public Health 2003;11(1):14-8.
Schaad 1990 {published data only}
  • Schaad UB, Suter S, Gianella-Borradori A, Pfenninger J, Auckenthaler R, Bernath O, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. New England Journal of Medicine 1990;322(3):141-7. [: CN-00064505]
Sorensen 1998 {published data only}
Strang 1992 {published data only}
  • Strang JR, Pugh EJ. Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. BMJ 1992;305(6846):141-3.
Wald 1995 {published data only}
  • Wald ER, Kaplan SL, Mason EOJ, Sabo D, Ross L, Arditi M, et al. Dexamethasone therapy for children with bacterial meningitis. Pediatrics 1995;95(1):21-31. [: CN-00174080]
Wylie 1997 {published data only}
  • Wylie PAL, Stevens D, Drake III W, Stuart J, Cartwright K. Epidemiology and clinical management of meningococcal disease in west Gloucestershire: retrospective, population based study. BMJ 1997;315(7111):774-9. [MEDLINE: 1997291389]

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Al-Tawfiq 2010
Baraff 1993
Belo 2010
  • Belo EFT, Farhat CK, Gaspari END. Comparison of dot-ELISA and standard ELISA for detection of Neisseria meningitidis outer membrane complex-specific antibodies. Brazilian Journal of Infectious Diseases 2010;14(1):35-40.
Boisier 2009
Booy 2001
  • Booy R, Habibi P, Nadel S, de Munter C, Britto Morrison JA, Levin M, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Archives of Disease in Childhood 2001;85:386-90.
Borg 2009
Bourke 2010
Brandtzaeg 1989
  • Brandtzaeg P,  Kierulf P,  Gaustad P,  Skulberg A,  Bruun JN,  Halvorsen S,  et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. Journal of Infectious Disease 1989;159(2):195-204.
Brandtzaeg 2005
  • Brandtzaeg P,  van Deuren M. Meningococcal infections at the start of the 21st century. Advances in Pediatrics 2005;52:129-62.
Campbell Collaboration 2008
  • The Campbell Collaboration. The Campbell Collaboration Economics Methods Policy Brief Version 1.0 April 2008. Available at :http://www.campbellcollaboration.org/artman2/uploads/1/Economic_Methods_Policy_Brief.pdf 2009 (accessed 21 July 2009).
Chanteau 2007
  • Chanteau S, Rose AM, Djibo S, Nato F, Boisier P. Biological diagnosis of meningococcal meningitis in the African meningitis belt: current epidemic strategy and new perspectives. Vaccine 2007;25(Suppl 1):A30-6.
Duke 2003
  • Duke T, Michael A, Mokela D, Wal T, Reeder J. Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?. Archives of Disease in Childhood 2003;88(6):536-9.
Edmond 2010
  • Edmond K,  Clark A,  Korczak VS,  Sanderson C,  Griffiths UK,  Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infectious Diseases 2010;10(5):317-28.
Eickhoff 1965
El Bashir 2003
El Filali 1993
  • el Filali M, Noum M, Chakib A, Zahraoui M, Himmich H. Ceftriaxone versus penicillin G in the short term treatment of meningococcal meningitis in adults. European Journal of Clinical Microbiology & Infectious Diseases 1993;12:766-8.
Ferguson 2002
  • Ferguson LE, Hormann MD. Neisseria meningitidis: presentation, treatment and prevention. Journal of Pediatric Health Care 2002;16:119-24.
Girgis 1998
  • Girgis N, Sultan Y, Frenck RW Jr, El-Gendy A, Farid Z, Mateczun A. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatric Infectious Diseases Journal 1998;17:816-9.
GRADE 2004
  • GRADE Working Group. GRADE Profiler; version 3.2. GRADE Working Group, 2004.
Granoff 2009
  • Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, Offit P editor(s). Vaccines. 5th Edition. Philadelphia: Saunders Elsevier, 2008:399-434.
Hackett 2002
  • Hackett SJ, Guiver M, Marsh J, Sills JA, Thomson APJ, Kaczmarski EB, et al. Meningococcal bacterial DNA load at presentation correlates with disease severity. Archives of Disease in Childhood 2002;86:44-6.
Hahné 2006
  • Hahné SJM, Charlett A, Purcell B, Samuelsson S, Camaroni I, Ehrhard I, et al. Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review. BMJ 2006;332:1299-303.
Higgins 2003
Higgins 2011a
  • Higgins JPT, Altman, DG, Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Chichester: Wiley-Blackwell, 2011.
Higgins 2011b
  • Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Chichester: Wiley-Blackwell, 2011.
Hill 2010
  • Hill DJ,  Griffiths NJ,  Borodina E,  Virji M. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clinical Science (London) 2010;9(118):547-64.
Hsu 2009
  • Hsu HE,  Shutt KA,  Moore MR,  Beall BW,  Bennett NM,  Craig AS,  et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. New England Journal of Medicine 2009;360(3):244-56.
Kanegaye 2001
  • Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 2001;108:1169-74.
Keeley 2006
Lefebvre 2011
  • Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Chichester, UK: Wiley-Blackwell, 2011.
Li 2011
NICE 2007
  • National Collaborating Centre for Women and Children's Health. Feverish illness in children. Assessment and initial management in children younger than 5 years. NICE Clinical Guideline CG47 (Available at: http://www.nice.org.uk/nicemedia/pdf/cg47niceguideline.pdf). National Institute for Health and Clinical Excellence, 2007.
NICE 2010
  • National Collaborating Centre for Women’s and Children’s Health. Bacterial meningitis and meningococcal septicaemia: the management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. NICE Clinical Guideline CG 102 (available at: http://www.nice.org.uk/CG102) 2010.
Pecoul 1999
Perera 2006
Piaggio 2006
  • Piaggio G, Elbourne D, Altman DG, Pocock SJ, Evans SJW, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials. An extension of the CONSORT statement. JAMA 2006;295:1152-60.
Prasad 2007
Ramakrishnan 2009
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rose 2010
Rosenstein 2001
Rouphael 2012
Schneider 2006
  • Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, Sim RB, et al. Functional significance of factor H binding to Neisseria meningitidis. Journal of Immunology 2006;176:7566-75.
Schubert-Unkmeir 2010
Schwartz 1989
  • Schwartz B, Moore PS, Broome CV. Global epidemiology of meningococcal disease. Clinical Microbiology Reviews 1989;2(Suppl):118-24.
Schünemann 2011
  • Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Chichester: Wiley-Blackwell, 2011.
SIGN 2008
  • Scottish Intercollegiate Guidelines Network. Management of invasive meningococcal disease in children and young people. A National Clinical Guideline: 102. 2008 (Available at: http://www.sign.ac.uk/pdf/sign102.pdf).
Sinclair 2010
Stephens 2007
Tunkel 1993
  • Tunkel AR, Scheld WM. Pathogenesis and pathophysiology of bacterial meningitis. Annual Reviews in Medicine 1993;44:103-20.
Wall 2013
Wang 2000
  • Wang VJ,  Malley R,  Fleisher GR,  Inkelis SH,  Kuppermann N. Antibiotic treatment of children with unsuspected meningococcal disease. Archives of Pediatrics and Adolescent Medicine 2000;154(6):556-60.
WHO 1995
  • WHO Working Group. Control of Epidemic Meningococcal Diseases: WHO Practical Guidelines. Lyon, France: Edition Foundation Marcel Merieux, 1995.
WHO 2004
  • World Health Organization. Meningococcal meningitis. http://www.who.int/csr/disease/meningococcal/en/ 2004 (accessed February 2004).
WHO 2007
  • World Health Organization. Risk of epidemic meningitis in Africa: a cause for concern. Weekly Epidemiological Record 2007;82:77-88.
WHO 2010
  • World Health Organization. Bacterial infections: meningococcal disease. World Health Organization (available at: http://www.who.int/vaccine_research/diseases/soa_bacterial/en/print.html) 2010.
Zalmanovici 2011
  • Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD004785.pub4]

References to other published versions of this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Sudarsanam 2008
Sudarsanam 2011
  • Sudarsanam T, Rupali P, Tharyan P, Abraham OC, Thomas K. Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD005437.pub2]